Hjem › Tyktarmskræft › Colorado
Tyktarmskræft kliniske forsøg i Colorado
19 studier for Tyktarmskræft søger deltagere på steder i Colorado.
Byer i Colorado
- Denver9 studier
- Aurora9 studier
- Pueblo6 studier
- Colorado Springs6 studier
- Highlands Ranch5 studier
- Longmont5 studier
- Lakewood5 studier
- Fort Collins4 studier
- Centennial4 studier
- Greeley3 studier
- Loveland3 studier
- Boulder3 studier
- Westminster3 studier
Officiel studietekst (engelsk)
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
- og 6 flere
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07283939Family Communications After Genetic Testing
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
- og 6 flere
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- University of Colorado Health - Harmony-Cancer Care and Hematology - Ft. Collins ( Site 0087), Fort Collins
- Rocky Mountain Cancer Centers (RMCC) ( Site 8000), Lone Tree
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06997497Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Rocky Mountain Cancer Centers, LLP, Aurora
- Rocky Mountain Cancer Centers - Boulder, Boulder
- Rocky Mountain Cancer Centers, LLP, Centennial
- og 18 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07222800Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Colorado Cancer Center, Aurora
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06128551A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- SCRI at HCA HealthONE, Denver
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07705334A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- GSK Investigational Site, Aurora
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07213609A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Sarah Cannon Research Institute Scri Oncology Partners, Aurora
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT07284849ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Colorado, Aurora
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT05059444Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
- Penrose-Saint Francis Healthcare, Colorado Springs
- og 11 flere
Rekrutterer
Alder 45 til 70 · Alle køn · Opdateret 2. sep. 2026 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- UCHealth University of Colorado Hospital, Aurora
- Intermountain Health Platte Valley Hospital, Brighton
- Penrose-Saint Francis Healthcare, Colorado Springs
- og 26 flere
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT05174169Integrated Cancer Repository for Cancer Research
- Advent Health, Greenwood Village
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- Sarah Cannon, SCRI Oncology Partners - Health One, Denver
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. jun. 2026 · NCT04678648A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Rocky Mountain Cancer Center - Primary, Denver
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT07011576Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sarah Cannon Research Institute, Denver
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT06239194Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- Department of Medicine-Gastroenterology, Denver Veterans Affairs Medical Center, University of Colorado Hospital, Denver
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 49 · Alle køn · Opdateret 24. apr. 2026 · NCT05732623Survivors Uniting for Remote Guided Exercise
- Human Performance Clinical Research Lab, Fort Collins
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 31. mar. 2026 · NCT07290309Improving Care for Rural Patients With Solid Tumors
- University of Colorado Hospital, Aurora
- Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
- og 10 flere
Rekrutterer
Alder 18 til 99 · Alle køn · Opdateret 5. feb. 2026 · NCT04916990SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Aurora
- Massive Bio SYNERGY-AI site, Denver
- Massive Bio SYNERGY-AI site, Littleton
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.